Rocket


Overview
Financials
News + Filings

 
 

Aset Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17
Revenues2.00.7
            Revenue growth193.4% 
Cost of goods sold8.94.1
Gross profit-7.0-3.5
            Gross margin-355.7%-518.5%
Selling, general and administrative0.00.0
EBIT-8.9-4.1
            EBIT margin-455.7%-618.5%
Pre-tax income-8.9-4.6
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income0.00.0
            Net margin-0.5%-0.7%
 
Diluted EPS($1.47)($0.79)
Shares outstanding (diluted)0.00.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy